BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2002
View Archived Issues
Efficacy of HCT-1026 as a treatment for overactive bladder in women
Read More
NS-8 reverses bladder hyperactivity in rats without affecting blood pressure or heart rate
Read More
Rho/Rho kinase pathway involved in spontaneous myogenic tone of isolated pig urethra
Read More
Enrollment completed in Repel-CV trial
Read More
Xention Discovery created following CeNeS technology acquisition
Read More
Kirin initiates phase II Mylovenge trials in Japan
Read More
TLK-286 to enter phase III by first quarter 2003
Read More
Ark and Tanabe collaborate on cachexia product development
Read More
Lexapro launched for major depressive disorder
Read More
Eligard 22.5 mg launched
Read More
Rosuvastatin: superior cholesterol control compared to atorvastatin and potential in stroke
Read More
IL-10 gene transfer suppresses autoimmune myocarditis in Lewis rats
Read More
Data presented at ESC 2002 support further clinical evaluation of AR-C69931MX in myocardial ischemia
Read More
ATL-962 significantly increases fat excretion in phase Ib studies
Read More
Improved oral bioavailability achieved in dihydropyridine Y1 receptor antagonists
Read More
Potent and orally active Lck inhibitors with activity in animal models of T-cell activation
Read More
Phase III Cidecin trial in endocarditis and bacteremia enrolls first patients
Read More
Symlin dose-titration study fully enrolled
Read More
Bay-43-9006 enters phase II
Read More
Arimidex approved in early breast cancer
Read More
Sumitomo presents novel agents for arthritis and bone disorders
Read More
New bronchodilators prepared and tested at Mercian
Read More
Novel inhibitors of VEGF expression covered by Mercian patent
Read More
New adenosine A2A antagonists and their use in Parkinson's disease described by Vernalis
Read More
Novel NOS inhibitors in early development at Fujisawa
Read More
Novel COX-1 inhibitors with analgesic activity described by Fujisawa
Read More
Novel antitumor compounds isolated from Clavularia corals
Read More